Skip to main content
. 2022 Oct 26;11(21):6300. doi: 10.3390/jcm11216300

Table 2.

Severity grading of AEs after mass praziquantel and albendazole administration.

Types of Adverse Events Cumulative Severity Grading
Number Incidence Mild (N/%) Moderate (N/%) Severe (N/%)
Headache 358 6.1 319 (89.1) 35 (9.8) 4 (1.1)
Abdominal pain 334 5.7 294 (88.0) 36 (0.8) 4 (1.2)
Vomiting 116 2.0 88 (75.9) 24 (20.7) 4 (3.4)
Dizziness 92 1.6 80 (87.0) 11 (12.0) 1 (1.1)
Nausea 89 1.5 74 (83.1) 13 (14.6) 2 (2.2)
Fever 71 1.2 58 (81.7) 12 (16.9) 1 (1.4)
Confusion 30 0.5 27 (90.0) 3 (10.0) 0
Diarrhea 29 0.5 20 (69.0) 7 (24.1) 2 (6.9)
Itching 21 0.4 21 (100) 0 0
Drowsiness 13 0.2 13 (100) 0 0
Loss of appetite 10 0.2 5 (50.0) 4 (40.0) 1(10.0)
Rash 4 0.1 4 (100) 0 0
Difficulty Breathing 3 0.1 2 (66.7) 1 (33.3) 0
Cough 1 0 1 (100) 0 0
Other symptoms 16 0.3 13 (81.3) 1 (6.3) 2 (12.5) *
Total 1187 13.3 1019 (85.8) 147 (12.4) 21 (1.8)

* Other symptoms—tremor.